Novartis AG - Tax Provision

Novartis AG's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Tax-Provision" stands at 2.04 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025.

Novartis AG's third quarter result of 0.266 Billion USD for the item "Tax Provision" represents a decrease of -47.53 percent compared to it's second quarter result.

Also, Novartis AG's third quarter result of 0.266 Billion USD for the item "Tax Provision" represents an increase of 33.00 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Novartis AG's third quarter result of 2.04 Billion USD for the item "Tax Provision" represents an increase of 3.35 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 108.82 percent compared to the value the year prior.
The 1 year change in percent is 108.82.
The 3 year change in percent is 14.00.
The 5 year change in percent is 2.98.
The 10 year change in percent is 52.28.

The Serie's long term average value is 1.47 Billion United States Dollars. It's latest available value, on 09/30/2025, is 38.86 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 03/31/2024, to it's latest available value, on 09/30/2025, is +203.43%.
The Serie's change in percent from it's maximum value, on 03/31/2022, to it's latest available value, on 09/30/2025, is -6.52%.